Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 99.1 Exhibit 99.1
- 23.2 Exhibit 23.2
- 23.1 Exhibit 23.1
- 14.1 Exhibit 14.1
- 10.10 Exhibit 10.10
- 10.9 Exhibit 10.9
- 10.8 Exhibit 10.8
- 10.7 Exhibit 10.7
- 10.6 Exhibit 10.6
- EX-FILING FEES Fee Table
- 10.5 Exhibit 10.5
- 10.4 Exhibit 10.4
- 10.3 Exhibit 10.3
- 10.2 Exhibit 10.2
- 10.1 Exhibit 10.1
- 5.1 Exhibit 5.1
- 3 Exhibit 3(II)
- 3 Exhibit 3(I)(9)
- 3 Exhibit 3(I)(8)
- 3 Exhibit 3(I)(7)
- 3 Exhibit 3(I)(6)
- 3 Exhibit 3(I)(5)
- 3 Exhibit 3(I)(4)
- 3 Exhibit 3(I)(3)
- 3 Exhibit 3(I)(2)
- 3 Exhibit 3(I)
- Download Excel data file
- View Excel data file
Associated filings
RGBP similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation in this Form S-1 of our report dated November 15, 2022, relating to the financial statements of Regen Biopharma, Inc. as of September 30, 2022 and 2021 and to all references to our firm included in this registration statement.
Certified Public Accountants
Lakewood, CO
April 10, 2023